You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 10, October 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  The Cutting Edge: Challenges in Medical and Surgical Therapeutics
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (5)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •HIV/AIDS
 •Immunotherapy
 •Alert me on articles by topic

Topical Tacrolimus for Effective Treatment of Eosinophilic Folliculitis Associated With Human Immunodeficiency Virus Infection

Laurence Toutous-Trellu, MD; Shahnaz Abraham, MD; Marc Pechère, MD; Pierre Chavaz, MD; Jan Lübbe, MD; Véronique Schiffer, MD; Bernard Hirschel, MD; Jean-Hilaire Saurat, MD; Vincent Piguet, MD, PhD
From the Departments of Dermatology and Venereology (Drs Toutous-Trellu, Abraham, Pechère, Chavaz, Lübbe, Saurat, and Piguet) and Internal Medicine, Division of Infectious Disease (Drs Toutous-Trellu, Schiffer, and Hirschel), University Hospital Geneva, Geneva, Switzerland.

Arch Dermatol. 2005;141:1203-1208.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

REPORT OF CASES

CASE 1

A 31-year-old man of Thai origin with human immunodeficiency virus (HIV) (Table, patient 1) was seen for pruritic lesions that had appeared 7 months earlier and had localized on his face (Figure 1A). At the time of presentation, he was profoundly immunosuppressed (CD4 cell count, 9/mm3 and viremia, HIV-1 RNA load of 100 000 copies/mL) and had been seen for a flare-up that had occurred 2 weeks earlier. Despite introduction 2 months later of treatment with highly active antiretroviral therapy (HAART) (indinavir, ritonavir, stavudine, and lamivudine) and topical clindamycin phosphate and ketoconazole, the lesions and pruritus persisted. The patient developed a secondary spread of lesions to his trunk and upper limbs 2 months after HAART was begun. Findings from . . . [Full Text of this Article]

CASE 2

THERAPEUTIC CHALLENGE

SOLUTION

COMMENT

AUTHOR INFORMATION


RELATED LETTERS

HIV Eosinophilic Folliculitis in Uganda
Robert Colebunders, Barbara Castelnuovo, and Helen Byakwaga
Arch Dermatol. 2006;142(7):934.
EXTRACT | FULL TEXT  

HIV Eosinophilic Folliculitis in Uganda—Reply
Laurence Toutous-Trellu and Vincent Piguet
Arch Dermatol. 2006;142(7):934-935.
EXTRACT | FULL TEXT  

RELATED ARTICLES

Evaluation of Coleman Lipostructure for Treatment of Facial Lipoatrophy in Patients With Human Immunodeficiency Virus and Parameters Associated With the Efficiency of This Technique
Marielle Burnouf, Marc Buffet, Michaël Schwarzinger, Philippe Roman, Patrick Bui, Marianne Prévot, Jean Deleuze, Jean Pierre Morini, Nathalie Franck, Isabelle Gorin, and Nicolas Dupin
Arch Dermatol. 2005;141(10):1220-1224.
ABSTRACT | FULL TEXT  

Dermatology-Related Epidemiologic and Clinical Concerns of Men Who Have Sex With Men, Women Who Have Sex With Women, and Transgender Individuals
Kenneth A. Katz and Timothy J. Furnish
Arch Dermatol. 2005;141(10):1303-1310.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

HIV Eosinophilic Folliculitis in Uganda.
Colebunders et al.
Arch Dermatol 2006;142:934-934.
FULL TEXT  

HIV Eosinophilic Folliculitis in Uganda--Reply
Toutous-Trellu and Piguet
Arch Dermatol 2006;142:934-935.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.